細胞程序化死亡在癲癇發生過程中的機制研究_Journal of Epilepsy

Authors：

高振 ¹ ,  翁檸 ^1,2

1. ;
2. ;

Corresponding?author：

翁檸, Email: 16138649@qq.com

Keywords：

癲癇; 細胞自噬; 細胞凋亡; 程序性壞死; 細胞焦亡

DOI：

10.7507/2096-0247.20210026

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

癲癇是一種病因復雜且發病機制尚未明確的慢性神經系統疾病。目前，國內外對癲癇開展了大量的研究。其中有研究認為，癲癇發生后，大腦海馬區出現了一些結構性的改變，這些改變就包括細胞程序化死亡。細胞程序化死亡的方式主要有四種，分別是細胞自噬、細胞凋亡、程序性壞死和細胞焦亡，這四種死亡方式有著各自的特點和相應的機制。文章就細胞程序化死亡在癲癇發生過程中的相關機制作一綜述，探討癲癇發生分別與細胞自噬、細胞凋亡、程序性壞死和細胞焦亡的關系。

Citation： 高振, 翁檸. 細胞程序化死亡在癲癇發生過程中的機制研究. Journal of Epilepsy, 2021, 7(2): 152-158. doi: 10.7507/2096-0247.20210026 Copy

1.	Bell GS, Neligan A, Sander JW. Commentary: epilepsia's survey on the prevalence of epilepsy. Epilepsia, 2015, 56(2): 166.
2.	唐穎瑩, 陸璐, 周東. 中國癲癇診斷治療現狀. 癲癇雜志, 2019, 5(3): 161-164.
3.	Gan J, Qu Y, Li J, et al. An evaluation of the links between microRNA, autophagy, and epilepsy. Rev Neurosci, 2015, 26(2): 225-237.
4.	Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol, 2018, 15: 490-503.
5.	Wang LX, Huang HH, Cai HC, et al. Maternal hypoxia increases hippocampal cell susceptibility to ischemia after middle cerebral artery occlusion in rat offspring. Folia Neuropathol, 2017, 55(4): 317-324.
6.	Mao XY, Jin MZ, Chen JF, et al. Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants. Pharmacol Ther, 2018, 183: 137-151.
7.	Dingledine R, Varvel NH, Dudek FE. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv Exp Med Biol, 2014, 813: 109-122.
8.	Lopes MW, Lopes SC, Costa AP, et al. Region-specific alterations of AMPA receptor phosphorylation and signaling pathways in the pilocarpine model of epilepsy. Neurochem Int, 2015, 87: 22-33.
9.	Galluzzi L, Bravo-San Pedro JM, Vitale I, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ, 2015, 22(1): 58-73.
10.	Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 2018, 25(3): 486-541.
11.	王棟梁, 宋海棟, 許可, 等. 新型抗癲癇藥物臨床應用研究. 中國醫學科學院學報, 2019, 41(4): 566-571.
12.	Tang F, Hartz AMS, Bauer B. Drug-resistant epilepsy: multiple hypotheses, few answers. Front Neurol, 2017, 8: 301.
13.	Levira F, Thurman DJ, Sander JW, et al. Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia, 2017, 58(1): 6-16.
14.	Zaccara G, Giannasi G, Oggioni R, et al. Convulsive status epilepticus study group of the uslcentro Toscana, Italy Challenges in the treatment of convulsive status epilepticus. Seizure, 2017, 47: 17-24.
15.	Gavvala JR, Schuele SU. JAMA patient page: Epilepsy. JAMA, 2016, 316(24): 2686.
16.	Wang J, Liu Y, Li XH, et al. Curcumin protects neuronal cells against status- epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis. Can J Physio Pharmacol, 2017, 95(5): 501-509.
17.	曹靜, 樊永平. 癲癇的中醫藥治療研究進展. 中華中醫藥雜志, 2008, 21(3): 181.
18.	Maiese K. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol, 2016, 82(5): 1245-1266.
19.	Maiese K. SIRT1 and stem cells: in the forefront with cardiovascular disease, neurodegeneration and cancer. World J Stem Cells, 2015, 7(2): 235-242.
20.	Maiese K. Programming apoptosis and autophagy with novel approaches for diabetes mellitus. Curr Neurovasc Res, 2015, 12(2): 173-188.
21.	Zhang X, Cui SS, Wallace AE, et al. Relations between brain pathology and temporal lobe epilepsy. J Neurosci, 2002, 22(14): 6052-6061.
22.	Onorati AV, Dyczynski M, Ojha R, et al. Targeting autophagy in cancer. Cancer, 2018, 124(16): 3307-3318.
23.	Zhao X, Liu G, Shen H, et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med, 2015, 35(3): 684-692.
24.	Antonioli M, Di RM, Piacentini M, et al. Emerging mechanisms in initiating and terminating autophagy. Trends Biochem Sci, 2017, 42(1): 28-41.
25.	Rocha-Ferreira E, Hristova M. Plasticity in the neonatal brain following hypoxic-ischaemic injury. Neural Plast, 2016, 2016: 4901014.
26.	宋園遠, 姜曉峰, 梁紅艷. 細胞自噬在腫瘤治療中的研究進展. 醫學綜述, 2019, 25(24): 4887-4891.
27.	Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell, 2012, 149(2): 274-293.
28.	Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest, 2015, 125(1): 25-32.
29.	Huang F, Wang BR, Wang YG. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World J Gastroenterol, 2018, 24(41): 4643-4651.
30.	Wu S, He YJ, Qiu XX, et al. Targeting the potent Beclin 1-UVRAG coiled-coil interaction with designed peptides enhances autophagy and endolysosomal trafficking. Proc Natl Acad Sci U S A, 2018, 115(25): E5669-E5678.
31.	Han TY, Guo M, Gan MX, et al. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1. Autophagy, 2018, 14(12): 2035-2048.
32.	楊炳欽, 陳君敏, 曾志勇. 調節自噬治療多發性骨髓瘤的研究進展. 中國實驗血液學雜志, 2020, 28(2): 700-703.
33.	金首躍, 武強. 細胞自噬、mTOR 信號通路在癲癇研究中的進展. 臨床神經病學雜志, 2015, 28(3): 232-234.
34.	Tiessen I, Abildgaard MH, Lubas M, et al. A high-throughput screen identifies the long non-coding RNA DRAIC as a regulator of autophagy. Oncogene, 2019, 38(26): 5127-5141.
35.	Xu XB, Lai YY, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep, 2019, 39(1): BSR20180992.
36.	Ichikawa N, Alves M, Pfeiffer S, et al. Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in mice. Cell Death Dis, 2017, 8(1): e2556.
37.	方春鳳, 狄朋桃, 吳洋. 中醫藥干預骨關節炎軟骨細胞凋亡研究進展. 中華中醫藥學刊, 2015, 33(8): 1919-1921.
38.	Liao Y, Yang F, Li X, et al. The impact of Caspase-8 on non-small cell lung cancer brain metastasis in II/III stage patient. Neoplasma, 2015: 13.
39.	楊濤, 費振海, 鐘興明. Caspase 家族與細胞凋亡的研究進展. 浙江醫學, 2018, 40(18): 2083-2087+2091.
40.	Lee HJ, Lee EK, Seo YE, et al. Roles of Bcl-2 and caspase-9 and -3 in CD30-induced human eosinophil apoptosis. J Microbiol Immunol Infect, 2017, 50(2): 145-152.
41.	劉春艷, 柴藝匯, 田興中, 等. 天麻破壁粉、凍干粉對戊四唑誘導癲癇大鼠海馬組織 Bcl-2、Bax、Caspase-3、GAT-1mRNA 及蛋白表達對比研究. 世界科學技術-中醫藥現代化, 2020, 22(1): 147-156.
42.	蘇勝有. Caspase 家族與神經細胞凋亡的研究進展. 世界最新醫學信息文摘, 2019, 19(80): 76-77.
43.	陳勝, 閔紅葉, 周書琴, 等. 亞低溫對腦缺血再灌注損傷大鼠神經細胞凋亡和 caspase-3 釋放的影響. 同濟大學學報, 2016, 37(6): 18-22+34.
44.	肖紅梅, 吳逸, 張婷, 等. 微囊藻毒素-LR 對人正常食管上皮細胞凋亡及對 Caspase-3 和 Caspase-9 蛋白表達的影響. 癌變·畸變·突變, 2017, 29(6): 418-421+426.
45.	楊娜, 龍藝, 孫麗明. 程序性細胞壞死在疾病中的研究進展. 中國細胞生物學學報, 2019, 41(8): 1490-1505.
46.	Seifert L, Miller G. Molecular pathways: the necrosome-A target for cancer therapy. Clin Cancer Res, 2017, 23(5): 1132-1136.
47.	張浩, 繆震元, 張萬年, 等. 程序性細胞壞死抑制劑的研究進展. 中國藥物化學雜志, 2019, 29(4): 305-316.
48.	吳軼群, 徐翀, 魏立彬. 細胞程序性壞死機制及其在神經退行性疾病發生發展中的作用. 世界最新醫學信息文摘, 2019, 19(78): 52-54.
49.	Zhang YY, Chen X, Gueydan C, et al. Plasma membrane changes during programmed cell deaths. Cell Res, 2018, 28(1): 9-21.
50.	Sai K, Parsons C, House JS, et al. Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing. J Cell Biol, 2019, 218(6): 1994-2005.
51.	Conrad M, Angeli JP, Vandenabeele P, et al. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov, 2016, 15(5): 348-366.
52.	Ting AT, Bertrand MJM. More to life than NF-κB in TNFR1 signaling. Trends Immunol, 2016, 37(8): 535-545.
53.	Messmer MN, Snyder AG, Oberst A. Comparing the effects of different cell death programs in tumor progression and immunotherapy. Cell Death Differ, 2019, 26(1): 115-129.
54.	龔捷, 徐曉飛. 細胞程序性壞死在惡性腫瘤中的研究進展. 巴楚醫學, 2019, 2(3): 116-119.
55.	李麗莎, 李燕京, 白玉賢. Gasdermin 家族調控腫瘤細胞焦亡的研究進展. 中國腫瘤, 2020, 29(4): 285-291.
56.	Ding JJ, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature, 2016, 535(7610): 111-116.
57.	Ruan J. Structural insight of gasdermin family driving pyroptotic cell death. Adv Exp Med Biol, 2019, 1172: 189-205.
58.	Shi JJ, Gao WQ, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci, 2017, 42(4): 245-254.
59.	Xia XJ, Wang X, Zheng Y, et al. What role does pyroptosis play in microbial infection? J Cell Physiol, 2019, 234(6): 7885-7892.
60.	Yang J, Liu ZH, Wang CP, et al. Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor. Proc Natl Acad Sci U S A, 2018, 115(26): 6792-6797.
61.	曾琬琴, 殷霞, 傅小龍. 細胞焦亡在腫瘤中的研究進展. 腫瘤學雜志, 2020, 26(5): 438-443.
62.	Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev, 2015, 265(1): 6-21.
63.	Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell, 2016, 165(4): 792-800.
64.	Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol, 2017, 27(9): 673-684.
65.	Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev, 2017, 277(1): 61-75.
66.	Yi YS. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses. Immunology, 2017, 152(2): 207-217.
67.	黃清宇, 杜楚江, 張雨竹, 等. 細胞焦亡研究進展. 中國免疫學雜志, 2020, 36(2): 245-250.
68.	李盼, 馬莉. 細胞焦亡在膿毒癥心功能障礙中的研究進展. 中國現代醫藥雜志, 2020, 22(2): 103-105.
69.	李潔, 李海霞, 閻春生, 等. 細胞焦亡與動脈粥樣硬化相關性的研究進展. 中國生物制品學雜志, 2020, 33(2): 207-212.
70.	Giorgi FS, Biagioni F, Lenzi P, et al. The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations. J Neural Transm, 2015, 122(6): 849-862.
71.	McMahon J, Huang XX, Yang J, et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis. J Neurosci, 2012, 32(45): 15704-15714.
72.	Yasin SA, Ali AM, Tata M, et al. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathol, 2013, 126(2): 207-218.
73.	Hosseinzadeh M, Nikseresht S, Khodagholi F, et al. Cannabidiol post-treatment alleviates rat epileptic-related behaviors and activates hippocampal cell autophagy pathway along with antioxidant defense in chronic phase of pilocarpine-induced seizure. J Mol Neurosci, 2016, 58(4): 432-440.
74.	Zheng ZL, Wu YQ, Li ZM, et al. Valproic acid affects neuronal fate and microglial function via enhancing autophagic flux in mice after traumatic brain injury. J Neurochem, 2019, 154(3): 274-300.
75.	Wu H, Lu MH, Wang W, et al. Lamotrigine reduces beta-site abetaPP-cleaving enzyme one protein levels through induction of autophagy. J Alzheimers Dis, 2015, 46(4): 863-876.
76.	Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA, 2008, 105(6): 2052-2057.
77.	Calderó J, Brunet N, Tarabal O, et al. Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord. Neuroscience, 2010, 165(4): 1353-1369.
78.	Wu Q, Zhang M, Liu XY, et al. CB2R orchestrates neuronal autophagy through regulation of the mTOR signaling pathway in the hippocampus of developing rats with status epilepticus. Int J Mol Med, 2020, 45(2): 475-484.
79.	Wang BH, Hou Q, Lu YQ, et al. Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res, 2018, 1678: 106-115.
80.	Yuen ESM, Troconiz IF. Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans? Seizure, 2015, 24: 21-27.
81.	Zhu XJ, Shen K, Bai Y, et al. NADPH oxidase activation is required for pentylenetetrazole kindling-induced hippocampal autophagy. Free Radic Biol Med, 2016, 94: 230-242.
82.	Hussein AM, Adel M, El-Mesery M, et al. l-carnitine modulates epileptic seizures in pentylenetetrazole-kindled rats via suppression of apoptosis and autophagy and upregulation of hsp70. Brain Sci, 2018, 8(3): 45.
83.	Wang L, Song LF, Chen XY, et al. MiR-181b inhibits P38/JNK signaling pathway to attenuate autophagy and apoptosis in juvenile rats with kainic acid-induced epilepsy via targeting TLR4. CNS Neurosci Ther, 2019, 25(1): 112-122.
84.	杜鵬, 木依提, 欒新平, 等. 外傷性癲癇模型海馬中自噬變化動態研究. 新疆醫學, 2013, 43(9): 7-10.
85.	Koshal P, Kumar P. Effect of liraglutide on corneal kindling epilepsy induced depression and cognitive impairment in mice. Neurochem Res, 2016, 41(7): 1741-1750.
86.	Koshal P, Kumar P. Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice. Mol Cell Biochem, 2016, 415(1-2): 77-87.
87.	Hussein AM, Eldosoky M, El-Shafey M, et al. Effects of GLP-1 receptor activation on a pentylenetetrazole-kindling rat model. Brain Sci, 2019, 9(5): 108.
88.	Cui Y, Liang Y, Liu YX, et al. High mobility group box 1 antibody represses autophagy and alleviates hippocampus damage in pilocarpine-induced mouse epilepsy model. Acta Histochem, 2020, 122(2): 151485.
89.	Attia GM, Elmansy RA, Elsaed WM. Neuroprotective effect of nilotinib on pentylenetetrazol-induced epilepsy in adult rat hippocampus: involvement of oxidative stress, autophagy, inflammation, and apoptosis. Folia Neuropathol, 2019, 57(2): 146-160.
90.	Engel T, Henshall DC. Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? Int J Physiol Pathophysiol Pharmacol, 2009, 1(2): 97-115.
91.	齊登斌, 郭振元, 閆波, 等. 依達拉奉對癲癇持續狀態大鼠神經元凋亡及 XIAP、Caspase-3 表達的影響. 中外醫療, 2019, 38(3): 23-25.
92.	Meng FX, You Y, Liu ZL, et al. Neuronal calcium signaling pathways are associated with the development of epilepsy. Mol Med Rep, 2015, 11(1): 196-202.
93.	Mori M, Burgess DL, Gefrides LA, et al. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ, 2004, 11(11): 1223-1233.
94.	Murphy B, Dunleavy M, Shinoda S, et al. Bcl-w protects hippocampus during experimental status epilepticus. Am J Pathol, 2007, 171(4): 1258-1268.
95.	Murphy BM, Engel T, Paucard A, et al. Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus. Cell Death Differ, 2010, 17(3): 459-468.
96.	Engel T, Murphy BM, Hatazaki S, et al. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J, 2010, 24(3): 853-861.
97.	Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev, 2017, 277(1): 76-89.
98.	劉春華, 劉捷. 神經元凋亡與 Caspase 家族及細胞周期研究進展. 人民軍醫, 2018, 61(7): 641-644.
99.	林若庭, 蔡若蔚, 張鵬飛, 等. 人難治性顳葉癲癇神經細胞凋亡與 Caspase3, 4 的表達. 中華醫學雜志, 2016, 96(7): 522-525.
100.	Gstrein T, Edwards A, P?istoupilová A, et al. Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans. Nat Neurosci, 2018, 21(2): 207-217.
101.	Nader MA, Ateyya H, El-Shafey M, et al. Sitagliptin enhances the neuroprotective effect of pregabalin against pentylenetetrazole-induced acute epileptogenesis in mice: implication of oxidative, inflammatory, apoptotic and autophagy pathways. Neurochem Int, 2018, 115: 11-23.
102.	Yang XR, Zhang HM, Wu JZ, et al. Humanin attenuates NMDA-induced excitotoxicity by inhibiting ROS-dependent JNK/p38 MAPK pathway. Int J Mol Sci, 2018, 19(10): 2982.
103.	Yang DD, Kuan CY, Whitmarsh AJ, et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature, 1997, 389(6653): 865-870.
104.	Mao XY, Zhou HH, Jin WL. Redox-related neuronal death and crosstalk as drug targets: focus on epilepsy. Front Neurosci, 2019, 13: 512.
105.	Zhang T, Balachandran S. Bayonets over bombs: RIPK3 and MLKL restrict Listeria without triggering necroptosis. J Cell Biol, 2019, 218(6): 1773-1775.
106.	杜瑞兵. 腫瘤細胞壞死因子 α 和 C 反應蛋白在大面積腦梗死性癲癇中的動態觀察. 中國衛生標準管理, 2016, 7(3): 145-146.
107.	Cai QY, Gan J, Luo R, et al. The role of necroptosis in status epilepticus-induced brain injury in juvenile rats. Epilepsy Behav, 2017, 75: 134-142.
108.	Lin DQ, Cai XY, Wang CH, et al. Optimal concentration of necrostatin-1 for protecting against hippocampal neuronal damage in mice with status epilepticus. Neural Regen Res, 2020, 15(5): 936-943.
109.	Moerke C, Jaco I, Dewitz C, et al. The anticonvulsive Phenhydan^? suppresses extrinsic cell death. Cell Death Differ, 2019, 26(9): 1631-1645.
110.	Zhang YY, Su SS, Zhao SB, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun, 2017, 8: 14329.
111.	Wang J, Li Y, Huang WH, et al. The protective effect of aucubin from eucommia ulmoides against status epilepticus by inducing autophagy and inhibiting necroptosis. Am J Chin Med, 2017, 45(3): 557-573.
112.	Maroso M, Balosso S, Ravizza T, et al. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J Intern Med, 2011, 270(4): 319-326.
113.	Tan CC, Zhang JG, Tan MS, et al. NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model. J Neuroinflammation, 2015, 12: 18.
114.	Wu Q, Wang H. The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus. Epilepsy Res, 2018, 148: 8-16.
115.	McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A, 2018, 115(26): E6065-E6074.
116.	Li J, Hao JH, Yao D, et al. Caspase-1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia. CNS Neurosci Ther, 2020, 26(9): 925-939.
117.	Bassil F, Fernagut PO, Bezard E, et al. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci U S A, 2016, 113(34): 9593-9598.

1. Bell GS, Neligan A, Sander JW. Commentary: epilepsia's survey on the prevalence of epilepsy. Epilepsia, 2015, 56(2): 166.
2. 唐穎瑩, 陸璐, 周東. 中國癲癇診斷治療現狀. 癲癇雜志, 2019, 5(3): 161-164.
3. Gan J, Qu Y, Li J, et al. An evaluation of the links between microRNA, autophagy, and epilepsy. Rev Neurosci, 2015, 26(2): 225-237.
4. Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol, 2018, 15: 490-503.
5. Wang LX, Huang HH, Cai HC, et al. Maternal hypoxia increases hippocampal cell susceptibility to ischemia after middle cerebral artery occlusion in rat offspring. Folia Neuropathol, 2017, 55(4): 317-324.
6. Mao XY, Jin MZ, Chen JF, et al. Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants. Pharmacol Ther, 2018, 183: 137-151.
7. Dingledine R, Varvel NH, Dudek FE. When and how do seizures kill neurons, and is cell death relevant to epileptogenesis? Adv Exp Med Biol, 2014, 813: 109-122.
8. Lopes MW, Lopes SC, Costa AP, et al. Region-specific alterations of AMPA receptor phosphorylation and signaling pathways in the pilocarpine model of epilepsy. Neurochem Int, 2015, 87: 22-33.
9. Galluzzi L, Bravo-San Pedro JM, Vitale I, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ, 2015, 22(1): 58-73.
10. Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 2018, 25(3): 486-541.
11. 王棟梁, 宋海棟, 許可, 等. 新型抗癲癇藥物臨床應用研究. 中國醫學科學院學報, 2019, 41(4): 566-571.
12. Tang F, Hartz AMS, Bauer B. Drug-resistant epilepsy: multiple hypotheses, few answers. Front Neurol, 2017, 8: 301.
13. Levira F, Thurman DJ, Sander JW, et al. Premature mortality of epilepsy in low- and middle-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia, 2017, 58(1): 6-16.
14. Zaccara G, Giannasi G, Oggioni R, et al. Convulsive status epilepticus study group of the uslcentro Toscana, Italy Challenges in the treatment of convulsive status epilepticus. Seizure, 2017, 47: 17-24.
15. Gavvala JR, Schuele SU. JAMA patient page: Epilepsy. JAMA, 2016, 316(24): 2686.
16. Wang J, Liu Y, Li XH, et al. Curcumin protects neuronal cells against status- epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis. Can J Physio Pharmacol, 2017, 95(5): 501-509.
17. 曹靜, 樊永平. 癲癇的中醫藥治療研究進展. 中華中醫藥雜志, 2008, 21(3): 181.
18. Maiese K. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol, 2016, 82(5): 1245-1266.
19. Maiese K. SIRT1 and stem cells: in the forefront with cardiovascular disease, neurodegeneration and cancer. World J Stem Cells, 2015, 7(2): 235-242.
20. Maiese K. Programming apoptosis and autophagy with novel approaches for diabetes mellitus. Curr Neurovasc Res, 2015, 12(2): 173-188.
21. Zhang X, Cui SS, Wallace AE, et al. Relations between brain pathology and temporal lobe epilepsy. J Neurosci, 2002, 22(14): 6052-6061.
22. Onorati AV, Dyczynski M, Ojha R, et al. Targeting autophagy in cancer. Cancer, 2018, 124(16): 3307-3318.
23. Zhao X, Liu G, Shen H, et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med, 2015, 35(3): 684-692.
24. Antonioli M, Di RM, Piacentini M, et al. Emerging mechanisms in initiating and terminating autophagy. Trends Biochem Sci, 2017, 42(1): 28-41.
25. Rocha-Ferreira E, Hristova M. Plasticity in the neonatal brain following hypoxic-ischaemic injury. Neural Plast, 2016, 2016: 4901014.
26. 宋園遠, 姜曉峰, 梁紅艷. 細胞自噬在腫瘤治療中的研究進展. 醫學綜述, 2019, 25(24): 4887-4891.
27. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell, 2012, 149(2): 274-293.
28. Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest, 2015, 125(1): 25-32.
29. Huang F, Wang BR, Wang YG. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World J Gastroenterol, 2018, 24(41): 4643-4651.
30. Wu S, He YJ, Qiu XX, et al. Targeting the potent Beclin 1-UVRAG coiled-coil interaction with designed peptides enhances autophagy and endolysosomal trafficking. Proc Natl Acad Sci U S A, 2018, 115(25): E5669-E5678.
31. Han TY, Guo M, Gan MX, et al. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1. Autophagy, 2018, 14(12): 2035-2048.
32. 楊炳欽, 陳君敏, 曾志勇. 調節自噬治療多發性骨髓瘤的研究進展. 中國實驗血液學雜志, 2020, 28(2): 700-703.
33. 金首躍, 武強. 細胞自噬、mTOR 信號通路在癲癇研究中的進展. 臨床神經病學雜志, 2015, 28(3): 232-234.
34. Tiessen I, Abildgaard MH, Lubas M, et al. A high-throughput screen identifies the long non-coding RNA DRAIC as a regulator of autophagy. Oncogene, 2019, 38(26): 5127-5141.
35. Xu XB, Lai YY, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep, 2019, 39(1): BSR20180992.
36. Ichikawa N, Alves M, Pfeiffer S, et al. Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in mice. Cell Death Dis, 2017, 8(1): e2556.
37. 方春鳳, 狄朋桃, 吳洋. 中醫藥干預骨關節炎軟骨細胞凋亡研究進展. 中華中醫藥學刊, 2015, 33(8): 1919-1921.
38. Liao Y, Yang F, Li X, et al. The impact of Caspase-8 on non-small cell lung cancer brain metastasis in II/III stage patient. Neoplasma, 2015: 13.
39. 楊濤, 費振海, 鐘興明. Caspase 家族與細胞凋亡的研究進展. 浙江醫學, 2018, 40(18): 2083-2087+2091.
40. Lee HJ, Lee EK, Seo YE, et al. Roles of Bcl-2 and caspase-9 and -3 in CD30-induced human eosinophil apoptosis. J Microbiol Immunol Infect, 2017, 50(2): 145-152.
41. 劉春艷, 柴藝匯, 田興中, 等. 天麻破壁粉、凍干粉對戊四唑誘導癲癇大鼠海馬組織 Bcl-2、Bax、Caspase-3、GAT-1mRNA 及蛋白表達對比研究. 世界科學技術-中醫藥現代化, 2020, 22(1): 147-156.
42. 蘇勝有. Caspase 家族與神經細胞凋亡的研究進展. 世界最新醫學信息文摘, 2019, 19(80): 76-77.
43. 陳勝, 閔紅葉, 周書琴, 等. 亞低溫對腦缺血再灌注損傷大鼠神經細胞凋亡和 caspase-3 釋放的影響. 同濟大學學報, 2016, 37(6): 18-22+34.
44. 肖紅梅, 吳逸, 張婷, 等. 微囊藻毒素-LR 對人正常食管上皮細胞凋亡及對 Caspase-3 和 Caspase-9 蛋白表達的影響. 癌變·畸變·突變, 2017, 29(6): 418-421+426.
45. 楊娜, 龍藝, 孫麗明. 程序性細胞壞死在疾病中的研究進展. 中國細胞生物學學報, 2019, 41(8): 1490-1505.
46. Seifert L, Miller G. Molecular pathways: the necrosome-A target for cancer therapy. Clin Cancer Res, 2017, 23(5): 1132-1136.
47. 張浩, 繆震元, 張萬年, 等. 程序性細胞壞死抑制劑的研究進展. 中國藥物化學雜志, 2019, 29(4): 305-316.
48. 吳軼群, 徐翀, 魏立彬. 細胞程序性壞死機制及其在神經退行性疾病發生發展中的作用. 世界最新醫學信息文摘, 2019, 19(78): 52-54.
49. Zhang YY, Chen X, Gueydan C, et al. Plasma membrane changes during programmed cell deaths. Cell Res, 2018, 28(1): 9-21.
50. Sai K, Parsons C, House JS, et al. Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing. J Cell Biol, 2019, 218(6): 1994-2005.
51. Conrad M, Angeli JP, Vandenabeele P, et al. Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov, 2016, 15(5): 348-366.
52. Ting AT, Bertrand MJM. More to life than NF-κB in TNFR1 signaling. Trends Immunol, 2016, 37(8): 535-545.
53. Messmer MN, Snyder AG, Oberst A. Comparing the effects of different cell death programs in tumor progression and immunotherapy. Cell Death Differ, 2019, 26(1): 115-129.
54. 龔捷, 徐曉飛. 細胞程序性壞死在惡性腫瘤中的研究進展. 巴楚醫學, 2019, 2(3): 116-119.
55. 李麗莎, 李燕京, 白玉賢. Gasdermin 家族調控腫瘤細胞焦亡的研究進展. 中國腫瘤, 2020, 29(4): 285-291.
56. Ding JJ, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature, 2016, 535(7610): 111-116.
57. Ruan J. Structural insight of gasdermin family driving pyroptotic cell death. Adv Exp Med Biol, 2019, 1172: 189-205.
58. Shi JJ, Gao WQ, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci, 2017, 42(4): 245-254.
59. Xia XJ, Wang X, Zheng Y, et al. What role does pyroptosis play in microbial infection? J Cell Physiol, 2019, 234(6): 7885-7892.
60. Yang J, Liu ZH, Wang CP, et al. Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor. Proc Natl Acad Sci U S A, 2018, 115(26): 6792-6797.
61. 曾琬琴, 殷霞, 傅小龍. 細胞焦亡在腫瘤中的研究進展. 腫瘤學雜志, 2020, 26(5): 438-443.
62. Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev, 2015, 265(1): 6-21.
63. Rathinam VA, Fitzgerald KA. Inflammasome complexes: emerging mechanisms and effector functions. Cell, 2016, 165(4): 792-800.
64. Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol, 2017, 27(9): 673-684.
65. Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev, 2017, 277(1): 61-75.
66. Yi YS. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses. Immunology, 2017, 152(2): 207-217.
67. 黃清宇, 杜楚江, 張雨竹, 等. 細胞焦亡研究進展. 中國免疫學雜志, 2020, 36(2): 245-250.
68. 李盼, 馬莉. 細胞焦亡在膿毒癥心功能障礙中的研究進展. 中國現代醫藥雜志, 2020, 22(2): 103-105.
69. 李潔, 李海霞, 閻春生, 等. 細胞焦亡與動脈粥樣硬化相關性的研究進展. 中國生物制品學雜志, 2020, 33(2): 207-212.
70. Giorgi FS, Biagioni F, Lenzi P, et al. The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations. J Neural Transm, 2015, 122(6): 849-862.
71. McMahon J, Huang XX, Yang J, et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis. J Neurosci, 2012, 32(45): 15704-15714.
72. Yasin SA, Ali AM, Tata M, et al. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis. Acta Neuropathol, 2013, 126(2): 207-218.
73. Hosseinzadeh M, Nikseresht S, Khodagholi F, et al. Cannabidiol post-treatment alleviates rat epileptic-related behaviors and activates hippocampal cell autophagy pathway along with antioxidant defense in chronic phase of pilocarpine-induced seizure. J Mol Neurosci, 2016, 58(4): 432-440.
74. Zheng ZL, Wu YQ, Li ZM, et al. Valproic acid affects neuronal fate and microglial function via enhancing autophagic flux in mice after traumatic brain injury. J Neurochem, 2019, 154(3): 274-300.
75. Wu H, Lu MH, Wang W, et al. Lamotrigine reduces beta-site abetaPP-cleaving enzyme one protein levels through induction of autophagy. J Alzheimers Dis, 2015, 46(4): 863-876.
76. Fornai F, Longone P, Cafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA, 2008, 105(6): 2052-2057.
77. Calderó J, Brunet N, Tarabal O, et al. Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord. Neuroscience, 2010, 165(4): 1353-1369.
78. Wu Q, Zhang M, Liu XY, et al. CB2R orchestrates neuronal autophagy through regulation of the mTOR signaling pathway in the hippocampus of developing rats with status epilepticus. Int J Mol Med, 2020, 45(2): 475-484.
79. Wang BH, Hou Q, Lu YQ, et al. Ketogenic diet attenuates neuronal injury via autophagy and mitochondrial pathways in pentylenetetrazol-kindled seizures. Brain Res, 2018, 1678: 106-115.
80. Yuen ESM, Troconiz IF. Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans? Seizure, 2015, 24: 21-27.
81. Zhu XJ, Shen K, Bai Y, et al. NADPH oxidase activation is required for pentylenetetrazole kindling-induced hippocampal autophagy. Free Radic Biol Med, 2016, 94: 230-242.
82. Hussein AM, Adel M, El-Mesery M, et al. l-carnitine modulates epileptic seizures in pentylenetetrazole-kindled rats via suppression of apoptosis and autophagy and upregulation of hsp70. Brain Sci, 2018, 8(3): 45.
83. Wang L, Song LF, Chen XY, et al. MiR-181b inhibits P38/JNK signaling pathway to attenuate autophagy and apoptosis in juvenile rats with kainic acid-induced epilepsy via targeting TLR4. CNS Neurosci Ther, 2019, 25(1): 112-122.
84. 杜鵬, 木依提, 欒新平, 等. 外傷性癲癇模型海馬中自噬變化動態研究. 新疆醫學, 2013, 43(9): 7-10.
85. Koshal P, Kumar P. Effect of liraglutide on corneal kindling epilepsy induced depression and cognitive impairment in mice. Neurochem Res, 2016, 41(7): 1741-1750.
86. Koshal P, Kumar P. Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice. Mol Cell Biochem, 2016, 415(1-2): 77-87.
87. Hussein AM, Eldosoky M, El-Shafey M, et al. Effects of GLP-1 receptor activation on a pentylenetetrazole-kindling rat model. Brain Sci, 2019, 9(5): 108.
88. Cui Y, Liang Y, Liu YX, et al. High mobility group box 1 antibody represses autophagy and alleviates hippocampus damage in pilocarpine-induced mouse epilepsy model. Acta Histochem, 2020, 122(2): 151485.
89. Attia GM, Elmansy RA, Elsaed WM. Neuroprotective effect of nilotinib on pentylenetetrazol-induced epilepsy in adult rat hippocampus: involvement of oxidative stress, autophagy, inflammation, and apoptosis. Folia Neuropathol, 2019, 57(2): 146-160.
90. Engel T, Henshall DC. Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? Int J Physiol Pathophysiol Pharmacol, 2009, 1(2): 97-115.
91. 齊登斌, 郭振元, 閆波, 等. 依達拉奉對癲癇持續狀態大鼠神經元凋亡及 XIAP、Caspase-3 表達的影響. 中外醫療, 2019, 38(3): 23-25.
92. Meng FX, You Y, Liu ZL, et al. Neuronal calcium signaling pathways are associated with the development of epilepsy. Mol Med Rep, 2015, 11(1): 196-202.
93. Mori M, Burgess DL, Gefrides LA, et al. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ, 2004, 11(11): 1223-1233.
94. Murphy B, Dunleavy M, Shinoda S, et al. Bcl-w protects hippocampus during experimental status epilepticus. Am J Pathol, 2007, 171(4): 1258-1268.
95. Murphy BM, Engel T, Paucard A, et al. Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus. Cell Death Differ, 2010, 17(3): 459-468.
96. Engel T, Murphy BM, Hatazaki S, et al. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J, 2010, 24(3): 853-861.
97. Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev, 2017, 277(1): 76-89.
98. 劉春華, 劉捷. 神經元凋亡與 Caspase 家族及細胞周期研究進展. 人民軍醫, 2018, 61(7): 641-644.
99. 林若庭, 蔡若蔚, 張鵬飛, 等. 人難治性顳葉癲癇神經細胞凋亡與 Caspase3, 4 的表達. 中華醫學雜志, 2016, 96(7): 522-525.
100. Gstrein T, Edwards A, P?istoupilová A, et al. Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans. Nat Neurosci, 2018, 21(2): 207-217.
101. Nader MA, Ateyya H, El-Shafey M, et al. Sitagliptin enhances the neuroprotective effect of pregabalin against pentylenetetrazole-induced acute epileptogenesis in mice: implication of oxidative, inflammatory, apoptotic and autophagy pathways. Neurochem Int, 2018, 115: 11-23.
102. Yang XR, Zhang HM, Wu JZ, et al. Humanin attenuates NMDA-induced excitotoxicity by inhibiting ROS-dependent JNK/p38 MAPK pathway. Int J Mol Sci, 2018, 19(10): 2982.
103. Yang DD, Kuan CY, Whitmarsh AJ, et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature, 1997, 389(6653): 865-870.
104. Mao XY, Zhou HH, Jin WL. Redox-related neuronal death and crosstalk as drug targets: focus on epilepsy. Front Neurosci, 2019, 13: 512.
105. Zhang T, Balachandran S. Bayonets over bombs: RIPK3 and MLKL restrict Listeria without triggering necroptosis. J Cell Biol, 2019, 218(6): 1773-1775.
106. 杜瑞兵. 腫瘤細胞壞死因子 α 和 C 反應蛋白在大面積腦梗死性癲癇中的動態觀察. 中國衛生標準管理, 2016, 7(3): 145-146.
107. Cai QY, Gan J, Luo R, et al. The role of necroptosis in status epilepticus-induced brain injury in juvenile rats. Epilepsy Behav, 2017, 75: 134-142.
108. Lin DQ, Cai XY, Wang CH, et al. Optimal concentration of necrostatin-1 for protecting against hippocampal neuronal damage in mice with status epilepticus. Neural Regen Res, 2020, 15(5): 936-943.
109. Moerke C, Jaco I, Dewitz C, et al. The anticonvulsive Phenhydan^? suppresses extrinsic cell death. Cell Death Differ, 2019, 26(9): 1631-1645.
110. Zhang YY, Su SS, Zhao SB, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat Commun, 2017, 8: 14329.
111. Wang J, Li Y, Huang WH, et al. The protective effect of aucubin from eucommia ulmoides against status epilepticus by inducing autophagy and inhibiting necroptosis. Am J Chin Med, 2017, 45(3): 557-573.
112. Maroso M, Balosso S, Ravizza T, et al. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J Intern Med, 2011, 270(4): 319-326.
113. Tan CC, Zhang JG, Tan MS, et al. NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model. J Neuroinflammation, 2015, 12: 18.
114. Wu Q, Wang H. The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus. Epilepsy Res, 2018, 148: 8-16.
115. McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A, 2018, 115(26): E6065-E6074.
116. Li J, Hao JH, Yao D, et al. Caspase-1 inhibition prevents neuronal death by targeting the canonical inflammasome pathway of pyroptosis in a murine model of cerebral ischemia. CNS Neurosci Ther, 2020, 26(9): 925-939.
117. Bassil F, Fernagut PO, Bezard E, et al. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci U S A, 2016, 113(34): 9593-9598.

Previous Article
拉考沙胺在老年癲癇患者中的應用進展
Next Article
腸道菌群與癲癇相關性研究進展

Journal of Epilepsy

細胞程序化死亡在癲癇發生過程中的機制研究

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content